Nikolaos Pyrsopoulos
Expertise in
23
conditions

Dr. Nikolaos Pyrsopoulos

Transplant Surgery | Gastroenterology
33 Overlook Road, Suite 201, 
Summit, NJ 
On Staff At
Accepting New Patients
30 Years of Experience
Expertise in
23
conditions
33 Overlook Road, Suite 201, 
Summit, NJ 

Overview

Nikolaos Pyrsopoulos is a Transplant Surgeon and a Gastroenterologist in Summit, New Jersey. Dr. Pyrsopoulos has been practicing medicine for over 30 years is highly rated in 23 conditions, according to our data. His top areas of expertise are Liver Failure, Hepatorenal Syndrome, Hepatitis, Liver Transplant, and Endoscopy. Dr. Pyrsopoulos is currently accepting new patients.

His clinical research consists of co-authoring 100 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Athens University , School Of Medicine

Residency

University of Miami Hospitals and Clinics

Specialties

Transplant Surgery
Gastroenterology

Licenses

Internal Medicine in NY

Board Certifications

American Board Of Internal Medicine

Fellowships

University of Miami
University of Miami Hospitals and Clinics

Hospital Affiliations

Overlook Medical Center
Atlantic Medical Group

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Atlantic Medical Group Gastroenterology at Summit
33 Overlook Road, Suite 201, Summit, NJ 07901
Other Locations
Atlantic Medical Group Gastroenterology at Morristown
435 South Street, Suite 230A, Morristown, NJ 07960

Additional Areas of Focus

Dr. Pyrsopoulos has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 2, Open-label, Multicenter Study to Investigate the Efficacy, Safety, and Pharmacokinetics of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Patients With Previously Treated Hepatocellular Unresectable Carcinoma
A Phase 2, Open-label, Multicenter Study to Investigate the Efficacy, Safety, and Pharmacokinetics of the Anti-PD-1 Monoclonal Antibody BGB-A317 in Patients With Previously Treated Hepatocellular Unresectable Carcinoma
Enrollment Status: Completed
Publish Date: October 26, 2024
Intervention Type: Drug
Study Drug: Tislelizumab
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
Enrollment Status: Terminated
Publish Date: January 25, 2019
Intervention Type: Biological, Other
Study Phase: Phase 3
68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma
68Gallium Citrate Imaging in Newly Diagnosed Hepatocellular Carcinoma
Enrollment Status: Unknown
Publish Date: January 03, 2019
Intervention Type: Drug
Study Drug: 68Gallium Citrate
Study Phase: Phase 2
View 5 Less Clinical Trials

100 Total Publications

Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis.
Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis.
Journal: Scientific reports
Published: August 22, 2025
Similar Doctors
Gene Y. Im
Expertise in
21
conditions
Dr. Gene Y. Im
Gastroenterology | Transplant Surgery
Expertise in
21
conditions
Dr. Gene Y. Im
Gastroenterology | Transplant Surgery

CUIMC/Presbyterian Hospital And Vanderbilt Clinic

622 West 168th Street, 
New York, NY 
 (7.1 miles away)
212-305-0914
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dr. Gene Im is a transplant hepatologist and the Director of the Alcohol-associated Liver Disease Program at Columbia known as ADAPT (Advanced inter-Disciplinary Alcohol liver Program and Treatment), a patient-centered, integrated care and research program for patients with alcohol-associated liver disease (ALD). ADAPT is one of only a few integrated ALD clinics in the country.Dr. Im is an internationally recognized expert in ALD, including alcohol-associated hepatitis and liver transplantation based on his clinical focus and research achievements. He has co-authored several practice-changing articles, including the 2019 ALD Practice Guidance from AASLD, the 2024 MetALD Expert Position Statement, and the first experience of early liver transplantation for alcohol-associated hepatitis in North America.Currently, he is the Vice-Chair of the AASLD ALD Special Interest Group and serves on the Editorial Board for the journal Liver Transplantation. Dr. Im is also the founder of ALD-ALLY (Alcohol-associated Liver Disease patients deserve ALcohol LiteracY), an annual conference focused on actionable initiatives for advancing the science and care of patients with alcohol use disorder and ALD (www.ald-ally.com)Dr. Im is an Assistant Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University. Dr. Im is highly rated in 21 conditions, according to our data. His top areas of expertise are Hepatitis, Alcoholic Cirrhosis, Liver Failure, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Expertise in
26
conditions
Dr. Myron E. Schwartz
Transplant Surgery | General Surgery
Expertise in
26
conditions
Dr. Myron E. Schwartz
Transplant Surgery | General Surgery

Icahn School Of Medicine At Mount Sinai

13516 Roosevelt Ave, 
Flushing, NY 
 (7.6 miles away)
212-241-8035
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Myron Schwartz is a Transplant Surgeon and a General Surgeon in Flushing, New York. Dr. Schwartz is highly rated in 26 conditions, according to our data. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Hepatectomy, and Liver Transplant.

Patrick Northup
Expertise in
19
conditions
Dr. Patrick Northup
Transplant Surgery | Hepatology | Gastroenterology
Expertise in
19
conditions
Dr. Patrick Northup
Transplant Surgery | Hepatology | Gastroenterology

NYU Langone Transplant

403 East 34th Street, Floor 3, 
New York, NY 
 (0.1 miles away)
212-263-0461
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Patrick Northup is a Hepatologist and a Transplant Surgeon in New York, New York. Dr. Northup is highly rated in 19 conditions, according to our data. His top areas of expertise are Liver Failure, Ascites, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy. Dr. Northup is currently accepting new patients.

Frequently Asked Questions about Dr. Nikolaos Pyrsopoulos

How do I make an appointment with Dr. Nikolaos Pyrsopoulos?

You can book an appointment with Dr. Nikolaos Pyrsopoulos by calling their office at 908-522-5040. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Nikolaos Pyrsopoulos a top-rated expert for Liver Failure?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nikolaos Pyrsopoulos is classified as an Elite expert for Liver Failure, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Nikolaos Pyrsopoulos specialize in?

While Dr. Nikolaos Pyrsopoulos is a Transplant Surgery, they have specific expertise in Liver Failure, Hepatorenal Syndrome, and Hepatitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.

Does Dr. Nikolaos Pyrsopoulos participate in research or clinical trials?

Yes. Dr. Nikolaos Pyrsopoulos has published 100 articles and abstracts on conditions like Liver Failure. You can view a list of Dr. Nikolaos Pyrsopoulos's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Nikolaos Pyrsopoulos accept my insurance?

Dr. Nikolaos Pyrsopoulos accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 908-522-5040 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pyrsopoulos's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile